Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Apply
JNJ-79635322 vs. BCMAxCD3
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step